Category Archives: In the News

Hudis Takes Over at ASCO, Reflections on Survival, and Gabe’s Story

Posted on by

Dr. Clifford Hudis has been named the new CEO of the American Society of Clinical Oncology. In his new role, Hudis will continue Lichter’s vision of using “big data” to find new treatments and cures for cancer.

Vivian Rodriguez Archilla, PhD provides professional commentary on the emotional struggles of cancer on T.J. Sharpe’s blog post, “The Dark Side of Surviving Cancer“.

The world first met Gabriel through Brandon Stanton on Humans of New York. Gabe’s story was the first story told through Brandon’s camera lens at MSK’s pediatrics department. Voice of America did an in-depth story on Gabe and his family as well as Dr. Paul Meyers, Gabe’s oncologist here at MSK.

New in Genomic Data, Personalized Medicine and More…

Posted on by

Here are a few newsworthy items in the world of cancer research

  • As part of the National Cancer Moonshot initiative, the Genomic Data Commons will standardize accessible data so that it can be used by cancer researchers.  The plan is to integrate genomic and clinical data so it may ultimately serve as a resource for clinicians and their patients.
  • Research conducted by scientists in St. Jude’s Research Hospital suggest that pediatric leukemia patients treated with higher concentrations of methotrexate are more likely to experience impaired executive function later on in life. Their findings were published in the Journal of Clinical Oncology.
  • Through a meta-analysis, researchers at the University of California in the San Diego School of Medicine, reported that personalized medicine leads to better outcomes in patients with cancer. 346 studies for a three year period were analyzed. The results were published in JAMA Oncology.
  • A research group at Lund University in Sweden has discovered two new types of blood cancer in the pediatric population. The discovery came about through the application of next generation sequencing (NGS) platforms. The discovery may signal the greater use of personalized medicine, applicable to different patients. The research findings were published in Nature Communications.